Global Antiretroviral Therapy Market Insights and Forecast to 2028

Table Of Contents

1 Study Coverage

1.1 Antiretroviral Therapy Product Introduction 1.2 Market by Type 1.2.1 Global Antiretroviral Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 NNRTIs 1.2.3 NRTI 1.2.4 Multiclass Combination Products 1.2.5 Integrase Inhibitors 1.3 Market by Application 1.3.1 Global Antiretroviral Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered2 Executive Summary 2.1 Global Antiretroviral Therapy Sales Estimates and Forecasts 2017-2028 2.2 Global Antiretroviral Therapy Revenue Estimates and Forecasts 2017-2028 2.3 Global Antiretroviral Therapy Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Antiretroviral Therapy Sales by Region 2.4.1 Global Antiretroviral Therapy Sales by Region (2017-2022) 2.4.2 Global Sales Antiretroviral Therapy by Region (2023-2028) 2.5 Global Antiretroviral Therapy Revenue by Region 2.5.1 Global Antiretroviral Therapy Revenue by Region (2017-2022) 2.5.2 Global Antiretroviral Therapy Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa3 Competition by Manufacturers 3.1 Global Antiretroviral Therapy Sales by Manufacturers 3.1.1 Global Top Antiretroviral Therapy Manufacturers by Sales (2017-2022) 3.1.2 Global Antiretroviral Therapy Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antiretroviral Therapy in 2021 3.2 Global Antiretroviral Therapy Revenue by Manufacturers 3.2.1 Global Antiretroviral Therapy Revenue by Manufacturers (2017-2022) 3.2.2 Global Antiretroviral Therapy Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Antiretroviral Therapy Revenue in 2021 3.3 Global Antiretroviral Therapy Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Antiretroviral Therapy Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans4 Market Size by Type 4.1 Global Antiretroviral Therapy Sales by Type 4.1.1 Global Antiretroviral Therapy Historical Sales by Type (2017-2022) 4.1.2 Global Antiretroviral Therapy Forecasted Sales by Type (2023-2028) 4.1.3 Global Antiretroviral Therapy Sales Market Share by Type (2017-2028) 4.2 Global Antiretroviral Therapy Revenue by Type 4.2.1 Global Antiretroviral Therapy Historical Revenue by Type (2017-2022) 4.2.2 Global Antiretroviral Therapy Forecasted Revenue by Type (2023-2028) 4.2.3 Global Antiretroviral Therapy Revenue Market Share by Type (2017-2028) 4.3 Global Antiretroviral Therapy Price by Type 4.3.1 Global Antiretroviral Therapy Price by Type (2017-2022) 4.3.2 Global Antiretroviral Therapy Price Forecast by Type (2023-2028)5 Market Size by Application 5.1 Global Antiretroviral Therapy Sales by Application 5.1.1 Global Antiretroviral Therapy Historical Sales by Application (2017-2022) 5.1.2 Global Antiretroviral Therapy Forecasted Sales by Application (2023-2028) 5.1.3 Global Antiretroviral Therapy Sales Market Share by Application (2017-2028) 5.2 Global Antiretroviral Therapy Revenue by Application 5.2.1 Global Antiretroviral Therapy Historical Revenue by Application (2017-2022) 5.2.2 Global Antiretroviral Therapy Forecasted Revenue by Application (2023-2028) 5.2.3 Global Antiretroviral Therapy Revenue Market Share by Application (2017-2028) 5.3 Global Antiretroviral Therapy Price by Application 5.3.1 Global Antiretroviral Therapy Price by Application (2017-2022) 5.3.2 Global Antiretroviral Therapy Price Forecast by Application (2023-2028)6 North America 6.1 North America Antiretroviral Therapy Market Size by Type 6.1.1 North America Antiretroviral Therapy Sales by Type (2017-2028) 6.1.2 North America Antiretroviral Therapy Revenue by Type (2017-2028) 6.2 North America Antiretroviral Therapy Market Size by Application 6.2.1 North America Antiretroviral Therapy Sales by Application (2017-2028) 6.2.2 North America Antiretroviral Therapy Revenue by Application (2017-2028) 6.3 North America Antiretroviral Therapy Market Size by Country 6.3.1 North America Antiretroviral Therapy Sales by Country (2017-2028) 6.3.2 North America Antiretroviral Therapy Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada7 Europe 7.1 Europe Antiretroviral Therapy Market Size by Type 7.1.1 Europe Antiretroviral Therapy Sales by Type (2017-2028) 7.1.2 Europe Antiretroviral Therapy Revenue by Type (2017-2028) 7.2 Europe Antiretroviral Therapy Market Size by Application 7.2.1 Europe Antiretroviral Therapy Sales by Application (2017-2028) 7.2.2 Europe Antiretroviral Therapy Revenue by Application (2017-2028) 7.3 Europe Antiretroviral Therapy Market Size by Country 7.3.1 Europe Antiretroviral Therapy Sales by Country (2017-2028) 7.3.2 Europe Antiretroviral Therapy Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia8 Asia Pacific 8.1 Asia Pacific Antiretroviral Therapy Market Size by Type 8.1.1 Asia Pacific Antiretroviral Therapy Sales by Type (2017-2028) 8.1.2 Asia Pacific Antiretroviral Therapy Revenue by Type (2017-2028) 8.2 Asia Pacific Antiretroviral Therapy Market Size by Application 8.2.1 Asia Pacific Antiretroviral Therapy Sales by Application (2017-2028) 8.2.2 Asia Pacific Antiretroviral Therapy Revenue by Application (2017-2028) 8.3 Asia Pacific Antiretroviral Therapy Market Size by Region 8.3.1 Asia Pacific Antiretroviral Therapy Sales by Region (2017-2028) 8.3.2 Asia Pacific Antiretroviral Therapy Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia9 Latin America 9.1 Latin America Antiretroviral Therapy Market Size by Type 9.1.1 Latin America Antiretroviral Therapy Sales by Type (2017-2028) 9.1.2 Latin America Antiretroviral Therapy Revenue by Type (2017-2028) 9.2 Latin America Antiretroviral Therapy Market Size by Application 9.2.1 Latin America Antiretroviral Therapy Sales by Application (2017-2028) 9.2.2 Latin America Antiretroviral Therapy Revenue by Application (2017-2028) 9.3 Latin America Antiretroviral Therapy Market Size by Country 9.3.1 Latin America Antiretroviral Therapy Sales by Country (2017-2028) 9.3.2 Latin America Antiretroviral Therapy Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina10 Middle East and Africa 10.1 Middle East and Africa Antiretroviral Therapy Market Size by Type 10.1.1 Middle East and Africa Antiretroviral Therapy Sales by Type (2017-2028) 10.1.2 Middle East and Africa Antiretroviral Therapy Revenue by Type (2017-2028) 10.2 Middle East and Africa Antiretroviral Therapy Market Size by Application 10.2.1 Middle East and Africa Antiretroviral Therapy Sales by Application (2017-2028) 10.2.2 Middle East and Africa Antiretroviral Therapy Revenue by Application (2017-2028) 10.3 Middle East and Africa Antiretroviral Therapy Market Size by Country 10.3.1 Middle East and Africa Antiretroviral Therapy Sales by Country (2017-2028) 10.3.2 Middle East and Africa Antiretroviral Therapy Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia11 Company Profiles 11.1 Gilead 11.1.1 Gilead Corporation Information 11.1.2 Gilead Overview 11.1.3 Gilead Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Gilead Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Gilead Recent Developments 11.2 F. Hoffmann-La Roche 11.2.1 F. Hoffmann-La Roche Corporation Information 11.2.2 F. Hoffmann-La Roche Overview 11.2.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 F. Hoffmann-La Roche Recent Developments 11.3 ViiV Healthcare 11.3.1 ViiV Healthcare Corporation Information 11.3.2 ViiV Healthcare Overview 11.3.3 ViiV Healthcare Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 ViiV Healthcare Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 ViiV Healthcare Recent Developments 11.4 Boehringer Ingelheim 11.4.1 Boehringer Ingelheim Corporation Information 11.4.2 Boehringer Ingelheim Overview 11.4.3 Boehringer Ingelheim Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Boehringer Ingelheim Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Boehringer Ingelheim Recent Developments 11.5 Janssen Pharmaceuticals 11.5.1 Janssen Pharmaceuticals Corporation Information 11.5.2 Janssen Pharmaceuticals Overview 11.5.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Janssen Pharmaceuticals Recent Developments 11.6 Mylan 11.6.1 Mylan Corporation Information 11.6.2 Mylan Overview 11.6.3 Mylan Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Mylan Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Mylan Recent Developments 11.7 Abbvie 11.7.1 Abbvie Corporation Information 11.7.2 Abbvie Overview 11.7.3 Abbvie Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Abbvie Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Abbvie Recent Developments 11.8 Bionor Pharma 11.8.1 Bionor Pharma Corporation Information 11.8.2 Bionor Pharma Overview 11.8.3 Bionor Pharma Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Bionor Pharma Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Bionor Pharma Recent Developments 11.9 Vertex Pharmaceuticals 11.9.1 Vertex Pharmaceuticals Corporation Information 11.9.2 Vertex Pharmaceuticals Overview 11.9.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Vertex Pharmaceuticals Recent Developments12 Industry Chain and Sales Channels Analysis 12.1 Antiretroviral Therapy Industry Chain Analysis 12.2 Antiretroviral Therapy Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Antiretroviral Therapy Production Mode & Process 12.4 Antiretroviral Therapy Sales and Marketing 12.4.1 Antiretroviral Therapy Sales Channels 12.4.2 Antiretroviral Therapy Distributors 12.5 Antiretroviral Therapy Customers13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Antiretroviral Therapy Industry Trends 13.2 Antiretroviral Therapy Market Drivers 13.3 Antiretroviral Therapy Market Challenges 13.4 Antiretroviral Therapy Market Restraints14 Key Findings in The Global Antiretroviral Therapy Study15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer